July 25, 2011
US approves Merck's new coccidiosis vaccine
A new-generation version of a coccidiosis vaccine to substitute Coccivac-D by Merck Animal Health has received regulatory consent from the USDA.
Similar to all Coccivac vaccines, Coccivac-D2 enhances the bird's natural immunity against live Eimeria oocysts by offering a balanced, controlled does of the costly and highly prevalent disease. The vaccine is presently in 5,000-dose and 1,000-dose vials.
Merck's constant commitment to quality means that the production of vaccinal oocysts in Coccivac-D2 are checked for purity, quality and re-qualified by USDA. The most recent product will also assist to streamline output and cause Merck Animal Health's vaccines to have a better manufacturing process.